Show simple item record

dc.contributor.authorRoxas, Jennifer Lising
dc.contributor.authorMonasky, Ross Calvin
dc.contributor.authorRoxas, Bryan Angelo P.
dc.contributor.authorAgellon, Al B.
dc.contributor.authorMansoor, Asad
dc.contributor.authorKaper, James B.
dc.contributor.authorVedantam, Gayatri
dc.contributor.authorViswanathan, V.K.
dc.date.accessioned2018-12-05T22:54:24Z
dc.date.available2018-12-05T22:54:24Z
dc.date.issued2018
dc.identifier.citationJennifer Lising Roxas, Ross Calvin Monasky, Bryan Angelo P. Roxas, Al B. Agellon, Asad Mansoor, James B. Kaper, Gayatri Vedantam, V.K. Viswanathan, Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations, Cellular and Molecular Gastroenterology and Hepatology, 6(2), 2018, pp 163-180, https://doi.org/10.1016/j.jcmgh.2018.04.007.en_US
dc.identifier.issn2352345X
dc.identifier.pmid30003123
dc.identifier.doi10.1016/j.jcmgh.2018.04.007
dc.identifier.urihttp://hdl.handle.net/10150/631121
dc.description.abstractBACKGROUND & AIMS: The diarrheagenic pathogen, enteropathogenic Escherichia coli (EPEC), uses a type III secretion system to deliver effector molecules into intestinal epithelial cells (IECs). While exploring the basis for the lateral membrane separation of EPEC-infected IECs, we observed infection-induced loss of the desmosomal cadherin desmoglein-2 (DSG2). We sought to identify the molecule(s) involved in, and delineate the mechanisms and consequences of, EPEC-induced DSG2 loss. METHODS: DSG2 abundance and localization was monitored via immunoblotting and immunofluorescence, respectively. Junctional perturbations were visualized by electron microscopy, and cell-cell adhesion was assessed using dispase assays. EspH alanine-scan mutants as well as pharmacologic agents were used to evaluate impacts on desmosomal alterations. EPEC-mediated DSG2 loss, and its impact on bacterial colonization in vivo, was assessed using a murine model. RESULTS: The secreted virulence protein EspH mediates EPEC-induced DSG2 degradation, and contributes to desmosomal perturbation, loss of cell junction integrity, and barrier disruption in infected IECs. EspH sequesters Rho guanine nucleotide exchange factors and inhibits Rho guanosine triphosphatase signaling; EspH mutants impaired for Rho guanine nucleotide exchange factor interaction failed to inhibit RhoA or deplete DSG2. Cytotoxic necrotizing factor 1, which locks Rho guanosine triphosphatase in the active state, jasplakinolide, a molecule that promotes actin polymerization, and the lysosomal inhibitor bafilomycin A, respectively, rescued infected cells from EPEC-induced DSG2 loss. Wild-type EPEC, but not an espH-deficient strain, colonizes mouse intestines robustly, widens paracellular junctions, and induces DSG2 re-localization in vivo. CONCLUSIONS: Our studies define the mechanism and consequences of EPEC-induced desmosomal alterations in IECs. These perturbations contribute to the colonization and virulence of EPEC, and likely related pathogens. (Cell Mol Gastroenterol Hepatol 2018;6:163-180; https:/doi.org/10.1016/j.jcmgh.2018.04.007)en_US
dc.description.sponsorshipNational Institutes of Health [NIAID1R01AI081742, 1S10OD011981-01]; United States Department of Agriculture Co-op Research and Extension Services (USDA CSREES) Hatch Program [ARZT-5704100-A02-140, ARZT-570410-A-02-139]; US Department of Veterans Affairs [1I01BX001183-01]en_US
dc.language.isoenen_US
dc.publisherELSEVIER INCen_US
dc.relation.urlhttps://linkinghub.elsevier.com/retrieve/pii/S2352345X18300675en_US
dc.rights© 2018 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).en_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectEPECen_US
dc.subjectDesmogleinen_US
dc.subjectDSG2en_US
dc.subjectHost-Pathogen Interactionen_US
dc.titleEnteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbationsen_US
dc.typeArticleen_US
dc.contributor.departmentUniv Arizona, Sch Anim & Comparat Biomed Scien_US
dc.contributor.departmentUniv Arizona, BIO5 Inst Collaborat Resen_US
dc.contributor.departmentUniv Arizona, Dept Immunobiolen_US
dc.identifier.journalCELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGYen_US
dc.description.noteOpen access journal.en_US
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en_US
dc.eprint.versionFinal published versionen_US
dc.source.journaltitleCellular and Molecular Gastroenterology and Hepatology
dc.source.volume6
dc.source.issue2
dc.source.beginpage163
dc.source.endpage180
refterms.dateFOA2018-12-05T22:54:25Z


Files in this item

Thumbnail
Name:
1-s2.0-S2352345X18300675-main.pdf
Size:
6.202Mb
Format:
PDF
Description:
Final Published version

This item appears in the following Collection(s)

Show simple item record

© 2018 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Except where otherwise noted, this item's license is described as © 2018 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).